Health·3,530 stories
Health News — Page 132
FDA Rejects Replimune Drug, Probes Telehealth Fees
Health officials are flagging the growing financial ties between drugmakers and telehealth platforms, warning they may breach anti‑kickback rules and push costly prescriptions, while the FDA has just
McGill Team Finds Depression Brain Cells
Scientists at McGill University and the Douglas Institute applied single‑cell genomics to post‑mortem brain tissue, revealing that excitatory neurons and a microglia subtype are the cellular drivers o
STAT+: Will bargain-basement telehealth visits help pharma drive drug scripts?
Sprout Pharmaceuticals is pairing a $10 telehealth visit with a coupon code to funnel more patients toward its low‑libido drug Addyi, now approved for all women under 65. The arrangement, run through
Duodenal resurfacing cuts weight after semaglutide
A blinded, sham‑controlled trial presented at Digestive Disease Week shows that duodenal mucosal resurfacing, an endoscopic heat‑ablation of the duodenum, dramatically reduces weight regain after pati
RMIT's nanopillar plastic film kills 94% of viruses in tests
RMIT University scientists have created a flexible acrylic plastic film covered in nanopillars that physically tears viruses apart on contact, disabling about 94% of human parainfluenza virus particle
UC Irvine finds fatty acid restores vision in mice
UC Irvine researchers showed that injecting older mice with a targeted polyunsaturated fatty acid reversed age‑related retinal decline, restoring visual function and cellular aging markers, offering a
STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
At the AACR meeting, Revolution Medicines highlighted its RAS inhibitor daraxonrasib’s promising frontline pancreatic cancer data while unveiling a new catalytic compound, RM‑055, that can strip phosp
UKNNL Extracts Cancer Isotopes from Nuclear Waste
A surge in radioligand therapy is driving a global scramble for scarce radioactive isotopes. Researchers at the UK’s National Nuclear Laboratory are turning nuclear waste into usable lead, while firms
China Gene Therapy Restores Hearing in 90% of Patients
A Chinese gene‑therapy trial for hereditary deafness has shown striking results—90% of participants, including children and a 32‑year‑old adult, reported marked hearing gains. Published in Nature, the
Breast cancer type study 'critically under-funded'
Campaigners for lobular breast cancer—a stealthy form affecting 15 % of UK patients—are demanding a £20 m research programme after staging vigils outside Downing Street. The Lobular Moon Shot Project,
Bacteriophage in Bacteroides fragilis Linked to Cancer
Researchers at the University of Southern Denmark and Odense University Hospital have identified a previously unknown bacteriophage inside the common gut bacterium Bacteroides fragilis that is markedl
Neutrophil Blood Marker Flags Dementia Risk in 400K Study
NYU Langone researchers found that the neutrophil-to-lymphocyte ratio, a standard measure from routine blood counts, is linked to a higher risk of developing Alzheimer's and other dementias years befo
NASA Should Prioritize Immunology for Lunar Base
NASA’s Artemis II success speeds its lunar‑base agenda, yet spaceflight‑induced immune changes and evolving microbes threaten crew health on the Moon and Mars. The piece urges NASA to embed immunology
Thomas Goetz’s ‘Drug Story’ Podcast Covers 3,000 Drugs
Journalist Thomas Goetz uses his new “Drug Story” podcast to turn each of the over 3,000 medicines on pharmacy shelves into a narrative about health, society, and economics. By dissecting drugs like A
CDC’s Epidemic Intelligence Service Marks 75 Years
As the United States juggles overseas wars and delicate diplomacy, the CDC’s Epidemic Intelligence Service—now 75 years old—has quietly built a nationwide cadre of 4,300+ disease detectives ready to r
Pemafibrate & Telmisartan Reverse Fatty Liver, Study
While Barcelona's headlines have been dominated by football setbacks, a University of Barcelona team led by Marta Alegret and partnered with Uppsala University and CIBEROBN has shown that combining th
STAT+: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it
At the AACR meeting, Revolution Medicines reported that its next‑generation KRAS inhibitor daraxonrasib shows promising first‑line and combination activity in advanced pancreatic cancer, while the NCI
Kyverna to File FDA Submission for SPS CAR‑T Therapy
Kyverna Therapeutics reported that its one‑time personalized CAR‑T cell therapy boosted mobility and cut disability in patients with stiff person syndrome, a rare autoimmune disorder. The company will
Revolution Medicines’ KRAS drug doubles survival
At the AACR meeting, Revolution Medicines unveiled its KRAS inhibitor daraxonrasib, which more than doubled median overall survival for second‑line pancreatic cancer patients, adding six months of lif
Insurers Reject Medicare Pilot for Weight‑Loss Drugs
The Trump administration’s BALANCE pilot aimed to test Medicare coverage of obesity drugs at a $245‑per‑month price with a $50 senior copay, but insurers balked, forcing the government to fund the tre
Get the Health newsletter
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.